HN

Han Nianhe

Scientific Leadership (recently recruited)

NovoCodex Biopharmaceuticals

Therapeutic Areas

NovoCodex Biopharmaceuticals Pipeline

DrugIndicationPhase
ARX305Oncology (unspecified)Phase 1
ARX788Oncology (unspecified)Phase 1